BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17352172)

  • 1. [Clinico-pathological prognostic factors in malignant pleural mesothelioma].
    Nakano K; Shiota Y; Ono T; Taniyama K; Hiramoto T; Yamakido M
    Nihon Kokyuki Gakkai Zasshi; 2007 Feb; 45(2):153-9. PubMed ID: 17352172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.
    Fusco V; Ardizzoni A; Merlo F; Cinquegrana A; Faravelli B; De Palma M; Chessa L; Nicolò G; Serra M; Capaccio A
    Anticancer Res; 1993; 13(3):683-9. PubMed ID: 8317897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?
    Balduyck B; Trousse D; Nakas A; Martin-Ucar AE; Edwards J; Waller DA
    Ann Thorac Surg; 2010 Mar; 89(3):907-11. PubMed ID: 20172152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Richards WG; Sugarbaker DJ
    Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and survival in malignant pleural mesothelioma.
    Van Gelder T; Damhuis RA; Hoogsteden HC
    Eur Respir J; 1994 Jun; 7(6):1035-8. PubMed ID: 7925870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma.
    Edwards JG; Swinson DE; Jones JL; Muller S; Waller DA; O'Byrne KJ
    Chest; 2003 Nov; 124(5):1916-23. PubMed ID: 14605068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis.
    Baud M; Strano S; Dechartres A; Jouni R; Triponez F; Chouaid C; Forgez P; Damotte D; Roche N; Régnard JF; Alifano M
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1305-11. PubMed ID: 23072703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluating the role of palliative radiotherapy in malignant pleural mesothelioma.
    Jenkins P; Milliner R; Salmon C
    Eur J Cancer; 2011 Sep; 47(14):2143-9. PubMed ID: 21658936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma.
    Yan TD; Boyer M; Tin MM; Sim J; Kennedy C; McLean J; Bannon PG; McCaughan BC
    Ann Thorac Surg; 2009 May; 87(5):1552-6. PubMed ID: 19379903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma.
    Demirag F; Unsal E; Yilmaz A; Caglar A
    Chest; 2005 Nov; 128(5):3382-7. PubMed ID: 16304288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors according to the treatment schedule in malignant pleural mesothelioma.
    Ak G; Metintas S; Metintas M; Yildirim H; Erginel S; Kurt E; Alatas F; Cadirci O
    J Thorac Oncol; 2009 Nov; 4(11):1425-30. PubMed ID: 19752758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
    Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K
    Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for 100 patients with malignant pleural mesothelioma.
    Gonlugur U; Gonlugur TE
    Arch Environ Occup Health; 2010; 65(2):65-9. PubMed ID: 20439224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemetrexed in malignant pleural mesothelioma and the clinical outcome.
    Knuuttila A; Salomaa ER; Saikkonen S; Hurme S; Salo J
    Clin Respir J; 2012 Apr; 6(2):96-103. PubMed ID: 21651743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pleural mesothelioma: surgical management in 285 patients.
    Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
    Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.
    Burt BM; Rodig SJ; Tilleman TR; Elbardissi AW; Bueno R; Sugarbaker DJ
    Cancer; 2011 Nov; 117(22):5234-44. PubMed ID: 21523763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.
    Kao SC; Vardy J; Chatfield M; Corte P; Pavlakis N; Clarke C; van Zandwijk N; Clarke S
    Clin Lung Cancer; 2013 Jan; 14(1):70-7. PubMed ID: 22658812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.